The Consensus Panel 2 (CP2) of the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11) has reviewed and incorporated current data to update the recommendations for treatment approaches in patients with relapsed or refractory WM (RRWM). Their report is available here.